NCT00539162 2026-04-16
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
M.D. Anderson Cancer Center
Phase NA Recruiting
Clinical Trials
845 trialsNCT04615013 2026-04-16
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT05123807 2026-04-16
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06036810 2026-04-16
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT06268626 2026-04-16
DETECTR
University of British Columbia
Recruiting
NCT07223424 2026-04-16
PSI-Immune
University of Pittsburgh
Phase 2 Recruiting
NCT07303894 2026-04-16
A Study of Isoquercetin in People With Ovarian Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07532954 2026-04-16
The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support
M.D. Anderson Cancer Center
Recruiting
NCT03604315 2026-04-15
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT03682289 2026-04-15
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
Phase 2 Recruiting
NCT05039801 2026-04-15
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT05287451 2026-04-15
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT05559879 2026-04-15
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
Phase 1/2 Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT07458347 2026-04-15
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Phase 1 Recruiting
NCT07532434 2026-04-15
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Peking University Third Hospital
Recruiting
NCT05581121 2026-04-14
PAROLA
Institut Claudius Regaud
Phase 3 Recruiting
NCT06305299 2026-04-14
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
UNC Lineberger Comprehensive Cancer Center
Phase 1 Recruiting
NCT06527456 2026-04-14
INDIGO
Centre Hospitalier Intercommunal Creteil
Phase NA Recruiting
NCT06640075 2026-04-14
Act4CC
University Hospital, Geneva
Phase NA Recruiting
NCT05183984 2026-04-13
NIRVANA-1
ARCAGY/ GINECO GROUP
Phase 2 Recruiting
NCT05769517 2026-04-13
PROBE-II
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT05887609 2026-04-13
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
University of Colorado, Denver
Phase 2 Recruiting
NCT06039111 2026-04-13
IGNITE-V
Hamilton Health Sciences Corporation
Phase 2 Recruiting
NCT06710548 2026-04-13
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06751589 2026-04-13
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07062016 2026-04-13
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Mayo Clinic
Recruiting
NCT04878094 2026-04-09
A Study of Intra-operative Imaging in Women With Ovarian Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Recruiting
NCT06127446 2026-04-09
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
National Health Research Institutes, Taiwan
Recruiting
NCT06665945 2026-04-09
SENTRY
University of Utah
Recruiting
NCT07107334 2026-04-09
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
University of Florida
Phase 2 Recruiting
NCT07282158 2026-04-08
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
Fred Hutchinson Cancer Center
Phase NA Recruiting
NCT02637934 2026-04-07
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Abramson Cancer Center at Penn Medicine
Phase 1 Recruiting
NCT04294927 2026-04-06
TUBA-WISP-II
University Medical Center Nijmegen
Phase NA Recruiting
NCT05920798 2026-04-06
FRAPPE
Mayo Clinic
Phase 1/2 Recruiting
NCT04588402 2026-04-03
HPV-Vac-S
International Agency for Research on Cancer
Recruiting
NCT05752448 2026-04-03
POSTCARE-O
Baylor College of Medicine
Phase NA Recruiting
NCT07493876 2026-04-03
EPICH
Fondazione del Piemonte per l'Oncologia
Phase NA Recruiting
NCT07290894 2026-04-02
MITO VULVA-01
National Cancer Institute, Naples
Phase 2 Recruiting
NCT07508306 2026-04-02
Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
Faculty of Medicine of Tunis
Recruiting
NCT04291612 2026-04-01
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Memorial Sloan Kettering Cancer Center
Recruiting
NCT04486352 2026-04-01
EndoMAP
Alliance Foundation Trials, LLC.
Phase 1/2 Recruiting
NCT04779554 2026-04-01
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
Phase 2 Recruiting
NCT05080946 2026-04-01
Using Aspirin to Improve Immunological Features of Ovarian Tumors
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Recruiting
NCT06290193 2026-04-01
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06915727 2026-04-01
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Mayo Clinic
Phase 3 Recruiting
NCT04093388 2026-03-31
Pap
University of Alabama at Birmingham
Phase NA Recruiting
NCT07290309 2026-03-31
SURGE
Colorado State University
Phase NA Recruiting
NCT07451340 2026-03-31
Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women
Ankara University
Recruiting
NCT05952141 2026-03-30
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
Abramson Cancer Center at Penn Medicine
Phase NA Recruiting